Combination of a novel HDAC 6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma

Combination of a novel HDAC 6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myelomaCombination of a novel HDAC 6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma, Published online: 06 November 2017; doi:10.1038/leu.2017.322

Source: Leukemia - November 6, 2017 Category: Hematology Authors: A Ray D S Das Y Song T Hideshima Y-T Tai D Chauhan K C Anderson Source Type: research